Braveheart Bio, Inc.
BRVE
$27.03
$1.064.08%
NASDAQ
| 03/31/2026 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Net Income | -14.28M | -99.00K | |||
| Total Depreciation and Amortization | 2.00K | -- | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 1.76M | 94.00K | |||
| Change in Net Operating Assets | 7.33M | 5.00K | |||
| Cash from Operations | -5.19M | 0.00 | |||
| Capital Expenditure | -36.00K | -- | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -3.00M | -- | |||
| Cash from Investing | -3.04M | -- | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | -- | -- | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -363.00K | -- | |||
| Cash from Financing | -363.00K | -- | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -8.59M | -- | |||